-- 周二盘后交易中,原油期货结算价走高,此前特朗普总统延长了与伊朗的停火协议,但他仍维持对霍尔木兹海峡和德黑兰港口的海上封锁。 近月西德克萨斯中质原油期货上涨3.20%,至每桶90.22美元;布伦特原油期货上涨3.90%,至每桶99.14美元。 在与伊朗为期两周的停火协议将于周三到期前几个小时,特朗普在社交媒体上发文称,他应巴基斯坦调解人的要求延长了停火协议。伊朗官员尚未对此声明作出回应。 特朗普表示,停火协议将一直有效,直到伊朗领导层提出永久解决方案为止。 特朗普称伊朗政府“严重分裂”,并表示他是应巴基斯坦陆军元帅阿西姆·穆尼尔和总理谢赫巴兹·谢里夫的要求做出这一决定的。 “……我们被要求暂停对伊朗的攻击,直到伊朗领导人和代表能够提出统一的方案,”特朗普周二在社交媒体上发帖称。 然而,这位美国总统表示,美国将暂停对伊朗的新一轮攻击,但对霍尔木兹海峡的海上封锁将继续,直到“双方达成一致意见”。 Dan-Bunkering的策略师周二在一份报告中指出,原油市场一直深受新闻动态的影响,预计未来一周仍将如此。 伊朗指责美国违反了其在脆弱的停火协议开始时提出的十点框架下的承诺。 周二,伊朗外长阿巴斯·阿拉格奇表示,美国封锁伊朗港口是“战争行为”,因此违反了停火协议。 “封锁伊朗港口是战争行为,因此违反了停火协议,”阿拉格奇在社交媒体X上发帖称。“袭击商船并劫持船员更是严重的违规行为。” 美国战争部(前身为国防部)周二表示,美军在其破坏伊朗航运网络的行动中,拦截并登船检查了一艘受制裁的油轮。 “美军已在印度洋登船检查了原油油轮‘蒂法尼’号,这似乎是针对与伊朗有关的航运行动的进一步升级,”MarineTraffic在社交媒体X上发帖称。 Kpler战略家表示,尽管海峡的每日通行量略有增加,但仍远低于正常水平。 “商业活动仍然受到安全风险加剧的制约,包括过去四天内发生的三起新的袭击事件以及海上扫雷工作的持续不确定性,”分析人士表示。
Related Articles
Scotiabank Previews This Week's February and Preliminary March GDP for Canada
Canada reports gross domestic product for February and the preliminary estimate for March on Thursday, said Scotiabank.February was initially guided by Statistics Canada to have been tracking a 0.2% month-over-month gain last month. Updated estimates are still in the same ballpark, but investors also get important details on sector drivers, noted the bank.More meaningful may be the flash guidance, with no details, for March GDP, for which there is very little information so far, but a small gain is "feasible," stated Scotiabank.The outcome will further inform Q1 GDP growth tracking on a production/income basis using monthly GDP. It's feasible that growth is tracking close to the Bank of Canada's 1.8% January Monetary Policy Report estimate, but that's on an expenditure basis. The massive over 4% inventory drag on Q4 GDP could reverse as an added upside, pointed out the bank.One key is that consumer spending on goods is tracking a strong rebound in Q1 based on retail sales volumes. It's untrue that the economy isn't exhibiting rate sensitivity, a view that is disproportionately driven by a false understanding of what's keeping condo markets weak in Toronto and Vancouver, added Scotiabank.
Vicor Insider Sold Shares Worth $2,079,226, According to a Recent SEC Filing
Alvaro Doyle, Vice President and Chief Information Officer, on April 23, 2026, sold 8,000 shares in Vicor (VICR) for $2,079,226. Following the Form 4 filing with the SEC, Doyle has control over a total of 42 common shares of the company, with 42 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/751978/000182673026000002/xslF345X05/primary_doc.xmlPrice: $265.29, Change: $-8.24, Percent Change: -3.01%
BioMarin Seen Building Broader Rare-Disease Platform After Amicus Deal, Morgan Stanley Says
BioMarin Pharmaceutical (BMRN) is emerging as a broader rare-disease platform as its acquisition of Amicus Therapeutics (FOLD) adds two approved medicines and reduces reliance on Voxzogo, Morgan Stanley said Monday in a report.The Amicus deal reshapes BioMarin's outlook by adding Galafold and Pombiliti with Opfolda, products that fit the company's global commercial network, the report said. The therapies are expected to generate more than $1.3 billion in revenue by 2030, Morgan Stanley said.The acquisition is projected to accelerate revenue growth immediately after closing and to be accretive to non-GAAP earnings within 12 months, with "substantial accretion" beginning in 2027, the report said. BioMarin closed its $4.8 billion purchase of Amicus on Monday.Morgan Stanley resumed coverage on BioMarin stock with an overweight rating and a $120 price target.Price: $54.08, Change: $+0.90, Percent Change: +1.68%